Начало › Колоректален рак › Охайо › Cleveland
Клинични проучвания за Колоректален рак в Cleveland, OH
24 проучвания за Колоректален рак търсят участници в обекти в и около Cleveland (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- Louis Stokes Cleveland VA Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Набиране на участнициФаза 2
- Cleveland Clinic - Oncology Department, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Набиране на участнициФаза 1
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Набиране на участнициФаза 3
- University Hospital of Cleveland, Cleveland
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Набиране на участнициФаза 3
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
- Taussig Cancer Insititute Cleveland Clinic, Cleveland
- и още 2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набиране на участнициФаза 1/2
- Cleveland Clinic, Cleveland
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Набиране на участнициФаза 3
- Case Comprehensive Cancer Center, Cleveland
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Набиране на участници
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Набиране на участнициФаза 1
- Cleveland Clinic Foundation, Cleveland
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- Clinical Study Site, Cleveland
- Clinical Study Site, Cleveland
- Clinical Study Site, Mayfield Heights · на 12 мили
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Cleveland Clinic, Cleveland
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Набиране на участнициФаза 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Набиране на участнициФаза 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1
- Cleveland Clinic, Taussig Cancer Institute, Cleveland
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Набиране на участнициНаблюдателно проучване
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Cleveland Clinic, Cleveland
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Набиране на участнициФаза 1/2
- Cleveland Clinic Foundation, Cleveland
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Набиране на участнициФаза 1
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Набиране на участнициФаза 1/2
- Cleveland Clinic, Cleveland
Проучвания за Колоректален рак в други градове
- Houston, TX102 проучвания
- New York City, NY78 проучвания
- Nashville, TN69 проучвания
- Boston, MA63 проучвания
- Los Angeles, CA59 проучвания
- Arlington, VA52 проучвания
- St. Louis, MO50 проучвания
- San Antonio, TX46 проучвания
- Philadelphia, PA44 проучвания
- Grand Rapids, MI40 проучвания
- Baldwin Park, CA37 проучвания
- Chicago, IL34 проучвания
Други проучвания в Cleveland
- Рак на белия дроб с недребноклетъчен тип43 проучвания
- Рак (всички видове)36 проучвания
- Рак на гърдата35 проучвания
- Рак на простатата34 проучвания
- Сърдечна недостатъчност33 проучвания
- Рак на яйчниците30 проучвания
- Метастатичен рак30 проучвания
- Рак на белия дроб26 проучвания
- Сърдечно-съдово заболяване22 проучвания
- Ендометриален рак20 проучвания
- Остра миелоидна левкемия20 проучвания
- Болест на Крон19 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.